Abstract:Non cystic-fibrosis bronchiectasis (NCFB) is a complex chronic respiratory disease, characterised by excessive sputum production and abnormal permanent dilation of bronchi. Mucus accumulation leads to recurrent bacterial infections and increased bacterial load, causing vicious cycles of structural damage and decreased lung function. Respiratory physiotherapy management of NCFB includes airway clearance techniques and use of nebulised, hypertonic saline. Despite advances in treatment, a consistent relationship has been observed between gender and disease occurrence, with a higher prevalence amongst females. Furthermore, NCFB presents most aggressively amongst post-menopausal females, a group likely exposed to higher levels of progesterone (P4) over a longer period of time. The effects of gender-specific hormones on bacterial load and physiotherapy management of people living with NCFB remain unknown. The aim of this narrative review was to discuss the potential influence of gender specific hormones on NCFB disease progression and influence on physiotherapy, medical management and future research. SCOPUS and PUBMED electronic databases were used to conduct searches for relevant studies using specific inclusion and exclusion criteria. Secondary inclusion of relevant literature was obtained from primary paper references. Previous literature suggests that P4 may impair Cilia Beat Frequency (CBF) in airway epithelium. Reduction in CBF may further reduce ability to expectorate amongst individuals with NCFB, increasing bacterial load and likelihood of exacerbations, negatively impacting on disease progression. Furthermore, coadministration of Estrogen has been suggested to offer opposing effects to that of P4 only. These findings question whether hormonal levels may be monitored, controlled and optimised within management and treatment of females with NCFB to improve airway clearance, reduce exacerbations and improve quality of life. Larger scale, long-term trials are required to further explore the effects of gender specific hormones on NCFB and the viability of treatment with hormone replacement therapy. The reviews of this paper are available via the supplemental material section.

Carriage of Neisseria meningitidis (meningococci) in the sputum of people with cystic fibrosis (CF): Occupational health risks and mitigating interventions for physiotherapists

Attitudes to cross infection, nebuliser hygiene and antimicrobial resistance in people with cystic fibrosis: Results of an international survey

Lack of correlation between surface water area and infection with Pseudomonas aeruginosa and the non-tuberculous mycobacteria (NTMs) in patients with cystic fibrosis (CF)

Viability Ofpseudomonas Aeruginosain Cough Aerosols Generated by Persons with Cystic Fibrosis

Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients

Seasonal and climatic influence on respiratory infections in children with cystic fibrosis

Role of viable but non culturable cells in patients with cystic fibrosis in the era of highly effective modulator therapy

Cystic Fibrosis Carrier States Are Associated With More Severe Cases of Bronchiectasis

Transmission of Bacteria in Bronchiectasis and Chronic Obstructive Pulmonary Disease: Low Burden of Cough Aerosols

Influence of sex, season and environmental air quality on experimental human pneumococcal carriage acquisition: a retrospective cohort analysis

Musculoskeletal aspects of respiratory function in cystic fibrosis: a cross-sectional comparative study

Neutrophil serine proteases in cystic fibrosis: role in disease pathogenesis and rationale as a therapeutic target

Effectiveness of manual therapy interventions in cystic fibrosis care: a pilot study

Microbiology sampling in non-cystic fibrosis bronchiectasis cases from northern Alberta

P174 High Aerosol Production of Potentially Infectious Cough Aerosols in People with Cystic Fibrosis During Coughing

The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis

Implications for the Microbial Landscape in Cystic Fibrosis

Chlamydia pneumoniae and Mycoplasma pneumoniae in children with cystic fibrosis: impact on bacterial respiratory microbiota diversity

Practical Guidance for Clinical Microbiology Laboratories: Updated guidance for processing respiratory tract samples from people with cystic fibrosis

Clinical Significance of Mucor in Airway Culture of Immunocompetent Patients With Chronic Lung Disease

Gender differences in non-cystic fibrosis bronchiectasis severity and bacterial load: the potential role of hormones